Skip to main content

Table 1 Characteristics of patients and treatment delivered

From: Cardiac safety of the adjuvant Trastuzumab in a Moroccan population: observational monocentric study of about 100 patients

Characteristic

Age

46 [24-74]

menopausal Status

 postmenopausal

31%

 Premenopausal

69%

Breast

 right

53%

 Left

47%

Tumor size

 T1

11%

 T2

50%

 T3

26%

 T4

13%

Ganglion involvement

 Positive

71%

 Negative

29%

Hormone receptor status

 Positive

67%

 Negative

33%

Surgery

 radical

78%

 conservative

22%

Chemotherapy

 Anthracycline

40%

 Taxanes (sequential)

60%

Radiotherapy

93%

 Right breast

49%

 Left breast

44%